Comparing a low-cost eye scanner for Alzheimer's research
Part of Brain & nervous system, Mental health clinical trials.
This study uses a special, low-cost eye scanner to look at the back of the eye (retina) in people with early Alzheimer's or mild memory problems. It aims to find changes that might help with early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to understand and sign a consent form.
- You must have mild memory problems or Alzheimer's disease (confirmed by doctors), or be a healthy volunteer with no memory issues.
- Your vision in at least one eye must be 20/40 or better (with glasses if needed).
- You cannot have other eye problems like glaucoma, current cornea injury, or retinal damage.
- You cannot have diabetes.
- You cannot have had eye surgery other than cataract removal.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses detailed eye imaging (an eye scan) to look for signs related to probable Alzheimer’s disease and mild dementia. It may help researchers understand whether eye scans can reflect brain changes and improve detection.
This study uses a special camera (OCT) to take pictures of the retina (the back of your eye) to see if it can detect Alzheimer's disease very early. You may be eligible if you are either cognitively normal or have mild cognitive impairment, and have already had a test for Alzheimer's-related brain changes.
This trial uses a type of eye scan (OCT) to look at the retina in people with brain conditions like multiple sclerosis, Alzheimer's, Parkinson's, or migraines. It aims to see if these scans can help doctors learn more about the disease and monitor it over time.
This study is testing a new eye camera to see if it can help find early signs of Alzheimer's disease. It is for people aged 55 and older who either have mild to moderate Alzheimer's or do not have Alzheimer's.
This study uses detailed eye scans to look for changes that might relate to memory problems. You may be able to join if you are being seen for memory concerns and meet the health and eye-scan requirements.
This trial tests an investigational drug called AMDX-2011P for people with Alzheimer's disease. It looks at whether the drug affects the retina, which may be linked to brain changes in Alzheimer's.
Hear when a new Optical Coherence Tomography of Retina trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.